We then detected the expression patterns in podocytes treated with high glucose (HG, Figure 3b), advanced glycation end-products (AGEs, Figure 3c) or transforming growth factor-β1 (TGF-β1, Figure 3d) (the common detrimental factors in DN) in vitro. This evidence concerns the gene TGFB1 and liver dysplastic nodule.